The Safety and Immunogenicity of GTU(®)MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART

Previous studies have shown targeting different tissues via the transcutaneous (TC) and intramuscular injection (IM) with or without electroporation (EP) has the potential to trigger immune responses to DNA vaccination. The CUTHIVTHER 001 Phase I/II randomized controlled clinical trial was designed...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Immunol
Glavni autori: Haidari, G., Day, Suzanne, Wood, M., Ridgers, H., Cope, Alethea V., Fleck, Sue, Yan, Celine, Reijonen, Kalevi, Hannaman, Drew, Spentzou, Aggeliki, Hayes, Peter, Vogt, A., Combadiere, Behazine, Cook, Adrian, McCormack, Sheena, Shattock, Robin J.
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Immunology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6923267/
https://ncbi.nlm.nih.gov/pubmed/31921170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02911
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items